Jump Financial’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.92M Sell
1,235,324
-123,087
-9% -$772K 0.05% 480
2026
Q2
$7.72M Buy
1,358,411
+1,095,854
+417% +$5.36M 0.06% 349
2026
Q1
$1.13M Buy
262,557
+92,957
+55% +$518K 0.02% 876
2025
Q4
$1.52M Buy
+169,600
New +$1.05M 0.02% 800
2025
Q1
– Sell
-21,460
Closed -$57.1K – 1883
2024
Q4
$57.1K Sell
21,460
-12,213
-36% -$31.4K ﹤0.01% 1565
2024
Q3
$77.1K Buy
+33,673
New +$103K ﹤0.01% 1538
2022
Q2
– Sell
-124,300
Closed -$654K – 1894
2022
Q1
$654K Buy
+124,300
New +$698K 0.03% 695

Other funds holding NUVB

Jump Financial's NUVB Position: Q3 2026 in Review

Jump Financial reduced its Nuvation Bio (NUVB) stake by 9.1% in Q3 2026, selling an estimated $772K and leaving 1,235,324 shares worth $6.92M. The position accounts for 0.05% of the portfolio, ranked #480.

Jump Financial first reported a position in NUVB in Q1 2022 and has held it in 7 quarters since. The position peaked at $7.72M in Q2 2026. 260 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Jump Financial held 1,235,324 shares of Nuvation Bio worth $6.92M as of Q3 2026.
  • Jump Financial sold 123,087 Nuvation Bio shares in Q3 2026, an estimated $772K.
  • Nuvation Bio made up 0.05% of Jump Financial's portfolio in Q3 2026, its #480 holding.
  • Jump Financial first reported a position in Nuvation Bio in Q1 2022 and has held it in 7 quarters since.
  • Jump Financial's Nuvation Bio position peaked at $7.72M in Q2 2026.
  • 260 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.